LINC00511 promotes gastric cancer cell growth by acting as a ceRNA
作者机构:Department of General SurgeryWeifang People's HospitalWeifang 261041Shandong ProvinceChina Department of Anorectal SurgeryWeifang People's HospitalWeifang 261041Shandong ProvinceChina Department of Spine SurgeryWeifang People's HospitalWeifang 261041Shandong ProvinceChina
出 版 物:《World Journal of Gastrointestinal Oncology》 (世界胃肠肿瘤学杂志(英文版)(电子版))
年 卷 期:2020年第12卷第4期
页 面:394-404页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:LINC00511 miR-124-3p PDK4 Long noncoding RNAs Gastric cancer
摘 要:BACKGROUND Gastric cancer(GC)is one of the most aggressive malignancies,with a high incidence and poor prognosis ***,accumulating evidence has illustrated that long noncoding RNAs(lnc RNAs)play pivotal roles in many *** has been reported that LINC00511 contributes to tumorigenesis in various ***,the role of LINC00511 in GC cell growth remains mostly *** To determine whether the lnc RNA LINC00511 exerted its carcinogenic function in GC via the miR-124-3 p/PDK4 *** Cell culture and transfection,RNA extraction and quantitative real-time PCR,CCK-8 assay,Colony formation assay,Luciferase reporter assay,RIP assay,RNA pull-down assay,and Western blot analysis were used to show expression and mechanisms of LINC00511 in GC progression and *** assays were performed to verify the relationships among LINC00511,miR-124-3 p and PDK4 *** The expression of LINC00511 was remarkably upregulated in GC cells compared to that in corresponding normal cell *** to the controls,cell proliferation was inhibited,and cell apoptosis was increased upon LINC00511knockdown,demonstrating that LINC00511 influenced GC cell *** exploration of the molecular mechanism revealed that LINC00511 functioned as a molecular sponge of miR-124-3 p and that PDK4 was a downstream target of miR-124-3 p in *** assays showed that the overexpression of PDK4 could partly restore the inhibitory function of si-LINC00511 in *** These data demonstrate that LINC00511 promotes gastric cancer cell growth by acting as a ce RNA to regulate the miR-124-3 p/PDK4 axis,which may be a promising therapeutic target for GC.